AptarGroup Q4 core sales up 4%, adjusted EPS $0.92; guides Q1 $0.85-$0.93

APTARGROUP, INC.

2022-FY EPS reported $3.59 revenue$3,322,249,000

Q4 net income $59M (+2%), reported sales $796M (-2%), core sales +4%; adj EPS $0.92 (+5%).
Pharma segment core sales +8% driven by consumer healthcare and prescription; Beauty+Home core +2%.
Annual 2022 sales $3.32B (+3% reported, +9% core); adj EPS $3.79 (+5%).
Q1 2023 adj EPS guidance $0.85-$0.93; expects continued momentum in Pharma and beauty.
Board declared $0.38 quarterly dividend payable Feb 23; 29th consecutive year of increasing dividend.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

APTARGROUP, INC. reported financial results for the quarter and year ended December 31, 2022.

Period: the quarter and year ended December 31, 2022
Result: reported results

Exact text from the filing

On February 16, 2023, AptarGroup, Inc. announced certain information related to its results of operations for the quarter and year ended December 31, 2022. The press release regarding this announcement is furnished as Exhibit 99.1 hereto.

View on SEC.gov

36 earnings releases filed in the last 30 days. Browse all earnings releases →

APTARGROUP, INC. filing history →

Source: SEC EDGAR

accession 0000896622-23-000005

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.